Search
for
Sort by
Research 31–60 of 1000+
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Neuroimmunoendocrine circuitry of the ‘brain-skin connection’
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Alopecia and the Microbiome: A Future Therapeutic Target?
- Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- Identification and in-silico analysis of phytochemicals from Phyla nodiflora (L.): Potential bioactive compounds for therapeutic applications
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Novel potential therapeutic targets of alopecia areata
- Protein Kinase C as a Therapeutic Target
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- TGF-β Signaling: a Potential Therapeutic Target of Single Herbs and Extracts for Renal Fibrosis
- GBP1 as a machine learning-prioritized biomarker and therapeutic target for epstein-barr virus-induced clear cell renal cell carcinoma: multi-omics causal validation
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- KRT6A derived from mesenchymal stem cells as a potential biomarker and therapeutic target for alopecia areata: insights from multi-omics analysis and experimental evidence
- Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity
- Comprehensive RNA sequencing in primary murine keratinocytes and fibroblasts identifies novel biomarkers and provides potential therapeutic targets for skin-related diseases